735 related articles for article (PubMed ID: 11834588)
1. Brain function in Duchenne muscular dystrophy.
Anderson JL; Head SI; Rae C; Morley JW
Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
[TBL] [Abstract][Full Text] [Related]
2. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse.
Kueh SL; Dempster J; Head SI; Morley JW
Neurobiol Dis; 2011 Sep; 43(3):558-64. PubMed ID: 21601636
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.
Wu WC; Bradley SP; Christie JM; Pugh JR
J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
5. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
[TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes.
Chaussenot R; Edeline JM; Le Bec B; El Massioui N; Laroche S; Vaillend C
Neurobiol Learn Mem; 2015 Oct; 124():111-22. PubMed ID: 26190833
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
8. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment appears progressive in the mdx mouse.
Bagdatlioglu E; Porcari P; Greally E; Blamire AM; Straub VW
Neuromuscul Disord; 2020 May; 30(5):368-388. PubMed ID: 32360405
[TBL] [Abstract][Full Text] [Related]
10. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency.
Maresh K; Papageorgiou A; Ridout D; Harrison NA; Mandy W; Skuse D; Muntoni F
Brain; 2023 Jan; 146(1):252-265. PubMed ID: 35136951
[TBL] [Abstract][Full Text] [Related]
11. GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice.
Kueh SL; Head SI; Morley JW
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):207-10. PubMed ID: 17941889
[TBL] [Abstract][Full Text] [Related]
12. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse.
Vaillend C; Billard JM; Laroche S
Neurobiol Dis; 2004 Oct; 17(1):10-20. PubMed ID: 15350961
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.
Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R
Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658
[TBL] [Abstract][Full Text] [Related]
14. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice.
Vaillend C; Chaussenot R
Hum Mol Genet; 2017 Mar; 26(6):1041-1055. PubMed ID: 28087735
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
16. Why is early-onset atrial fibrillation uncommon in patients with Duchenne muscular dystrophy? Insights from the mdx mouse.
Nguyen MN; Hooper C; Stefanini M; Vrellaku B; Carnicer R; Wood MJ; Simon JN; Casadei B
Cardiovasc Res; 2024 Apr; 120(5):519-530. PubMed ID: 38270932
[TBL] [Abstract][Full Text] [Related]
17.
Stay TL; Miterko LN; Arancillo M; Lin T; Sillitoe RV
Dis Model Mech; 2019 Dec; 13(2):. PubMed ID: 31704708
[TBL] [Abstract][Full Text] [Related]
18. The role of dystrophin in the central nervous system: a mini review.
Sekiguchi M
Acta Myol; 2005 Oct; 24(2):93-7. PubMed ID: 16550924
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.
Xu S; Shi D; Pratt SJP; Zhu W; Marshall A; Lovering RM
Neuromuscul Disord; 2015 Oct; 25(10):764-72. PubMed ID: 26236031
[TBL] [Abstract][Full Text] [Related]
20. The neurobiology of duchenne muscular dystrophy: learning lessons from muscle?
Blake DJ; Kröger S
Trends Neurosci; 2000 Mar; 23(3):92-9. PubMed ID: 10675908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
